Status:
UNKNOWN
Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents
Lead Sponsor:
Shalvata Mental Health Center
Conditions:
Adolescent Depression
Eligibility:
All Genders
15-18 years
Phase:
PHASE1
PHASE2
Brief Summary
The investigators hypothesis that repetitive transcranial Stimulation (rTMS) is a safe and effective add-on therapy for resistent depression in adolescent patients. A group of adolescents suffering f...
Eligibility Criteria
Inclusion
- Age 15-18 years old
- Right hand dominant
- Suffering from major depression
- CDRS \> 60
- At least 3 months of current depressive episode
- Failed 2 drug trials (or 3 drug trials if trial terminated prematurely due to side effects) and at least 1 course of psychotherapy
- No contraindication for rtms (safety questionnaire)
- No change in pharmacotherapy in the last month
Exclusion
- Schizophrenia or psychotic symptoms
- Hypertension
- Epilepsy
- History of major head trauma
- Metal implements in the head
- History of neurosurgery
- History of severe head migraine
- History of hearing loss or sp cochlear transplantation
- Pregnancy
- Current drug abuse
- Unstable medical condition
- History of manic episode
- Current treatment with lithium or tricyclic or tetracyclic antidepressants
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01170520
Start Date
August 1 2010
Last Update
January 5 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shalvata Mental health Center
Hod HaSharon, Israel
2
Shalvata Mental Health Center
Hod HaSharon, Israel